A business in context

MBIO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-13 · 0001104659-26-116233 · Items 8.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-091061

  3. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-055598

  4. 4 · Ownership change

    Report date 2026-04-24 · 0001104659-26-049430

  5. 8-K · Current report

    Report date 2026-04-15 · 0001104659-26-044890 · Items 3.01

  6. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-032063

  7. 4 · Ownership change

    Report date 2026-01-02 · 0001429260-26-000002

  8. 4 · Ownership change

    Report date 2025-12-30 · 0001104659-25-125233

  9. 4 · Ownership change

    Report date 2025-12-30 · 0001104659-25-125232

  10. 4 · Ownership change

    Report date 2025-12-30 · 0001104659-25-125227

  11. 8-K · Current report

    Report date 2025-12-17 · 0001104659-25-124189 · Items 5.07,8.01,9.01

  12. DEF 14A · Proxy statement

    Report date 2025-12-22 · 0001104659-25-118122

  13. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-108468

  14. 4 · Ownership change

    Report date 2025-09-29 · 0001429260-25-000004

  15. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-010920

  16. 8-K · Current report

    Report date 2025-07-07 · 0001104659-25-066520 · Items 8.01,9.01

  17. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-007736

  18. 4 · Ownership change

    Report date 2025-04-24 · 0001104659-25-040237

  19. 4 · Ownership change

    Report date 2025-03-31 · 0001415889-25-009620

  20. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-003913

  21. 8-K · Current report

    Report date 2025-03-05 · 0001104659-25-020900 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2025-02-21 · 0001104659-25-018299 · Items 2.01,8.01,9.01

  23. 8-K · Current report

    Report date 2025-02-19 · 0001104659-25-016145 · Items 5.07

  24. 8-K · Current report

    Report date 2025-02-07 · 0001104659-25-013029 · Items 1.01,1.02

  25. 8-K · Current report

    Report date 2025-02-05 · 0001104659-25-011517 · Items 1.01,8.01,9.01

  26. 8-K · Current report

    Report date 2025-01-14 · 0001104659-25-004565 · Items 3.03,5.03,8.01,9.01

  27. 8-K · Current report

    Report date 2025-01-10 · 0001104659-25-002599 · Items 5.07

  28. 8-K · Current report

    Report date 2024-12-26 · 0001104659-25-000343 · Items 5.07

  29. DEF 14A · Proxy statement

    Report date 2024-12-26 · 0001558370-24-016070

  30. 8-K · Current report

    Report date 2024-11-12 · 0001104659-24-119756 · Items 3.01,5.02

  31. SC 13G/A · Ownership disclosure

    0001172661-24-005232

  32. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001558370-24-015048

  33. 8-K · Current report

    Report date 2024-11-06 · 0001104659-24-114835 · Items 5.08,8.01

  34. 8-K · Current report

    Report date 2024-10-23 · 0001104659-24-111500 · Items 1.01,3.02,5.02,8.01,9.01

  35. 8-K · Current report

    Report date 2024-09-10 · 0001104659-24-099829 · Items 3.01

  36. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001558370-24-012051

  37. 8-K · Current report

    Report date 2024-06-27 · 0001104659-24-077596 · Items 1.01,1.02,2.01,5.07,9.01

  38. SC 13D/A · Ownership disclosure

    0001104659-24-076303

  39. 8-K · Current report

    Report date 2024-06-19 · 0001104659-24-074043 · Items 1.01,3.02,8.01,9.01

  40. 8-K · Current report

    Report date 2024-05-31 · 0001104659-24-069131 · Items 1.01,1.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001680048MUSTANG BIO, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗